Literature DB >> 24397488

HLA-class II alleles in patients with drug-resistant pulmonary tuberculosis in Kazakhstan.

A B Kuranov1, U A Kozhamkulov, M N Vavilov, E S Belova, V L Bismilda, A H Alenova, S S Ismailov, K T Momynaliev.   

Abstract

The human leukocyte antigen (HLA) system has a major role in the regulation of the immune response as it is involved in the defense against pathogens. Some studies have reported that HLA class II genes play a strong role in severe cases of pulmonary tuberculosis (PTB) in several populations. Thus the aim of the study was to compare the HLA-class II alleles of patients with drug resistant tuberculosis with those of healthy controls from the same ethnic group in Kazakhstan. The aim of the present study was to evaluate the correlation of HLA-class II alleles by patients with drug resistant tuberculosis and the healthy controls of the same ethnic group in Kazakhstan. The HLA-class II alleles of 76 patients with tuberculosis (TB) and 157 healthy volunteers were investigated using sequence-based typing (SBT)-method. HLA-DQA1*03:02 HLA-DRB1*08:01 and DRB1*08:03 occurred more frequently (P = 0.05) in patients with drug resistant tuberculosis than in controls. We observed a possible association between certain HLA alleles and TB that are specific for the Kazakh population. Further studies are needed to confirm our findings using a larger number of patients with drug resistant tuberculosis.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Kazakhstan; human leukocyte antigen; tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24397488     DOI: 10.1111/tan.12279

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  The Relationship of HLA-DQ Alleles with Tuberculosis Risk: A Meta-analysis.

Authors:  Cuiping Li; Ying Zhou; Xue Xiang; Yang Zhou; Min He
Journal:  Lung       Date:  2015-05-26       Impact factor: 2.584

2.  Survey of major histocompatibility complex class II diversity in pig-tailed macaques.

Authors:  Julie A Karl; Katelyn E Heimbruch; Claire E Vriezen; Cassandra J Mironczuk; Dawn M Dudley; Roger W Wiseman; David H O'Connor
Journal:  Immunogenetics       Date:  2014-08-17       Impact factor: 2.846

Review 3.  Do HLA class II genes protect against pulmonary tuberculosis? A systematic review and meta-analysis.

Authors:  A Oliveira-Cortez; A C Melo; V E Chaves; A Condino-Neto; P Camargos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-13       Impact factor: 3.267

4.  Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury.

Authors:  Yifan Bao; Xiaochao Ma; Theodore P Rasmussen; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2018-03-15

5.  Polymorphisms of HLA-DRB1, -DQA1 and -DQB1 in inhabitants of Astana, the capital city of Kazakhstan.

Authors:  Alexandr B Kuranov; Mikhail N Vavilov; Gulshara Zh Abildinova; Ainur R Akilzhanova; Aisha N Iskakova; Elena V Zholdybayeva; Margarita N Boldyreva; Claudia A Müller; Kuvat T Momynaliev
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

6.  Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population.

Authors:  Dhêmerson Souza de Lima; Mauricio Morishi Ogusku; Maisa Porto Dos Santos; Cláudia Maria de Melo Silva; Vanessa Alves de Almeida; Irineide Assumpção Antunes; Antonio Luiz Boechat; Rajendranath Ramasawmy; Aya Sadahiro
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

7.  Association of human leukocyte antigens-DQB2/DPA1/DPB1 polymorphism and pulmonary tuberculosis in the Chinese Uygur population.

Authors:  Xue Wang; Xudong Cao; Wanjiang Zhang; Le Zhang; Lijun Lu; Xinyue Li; Saeed El-Ashram; Jiangdong Wu; Chuangfu Chen
Journal:  Mol Genet Genomic Med       Date:  2019-01-01       Impact factor: 2.183

8.  Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia.

Authors:  Dimitri Poddighe; Aida Turganbekova; Dana Baymukasheva; Zhazira Saduakas; Zhuldyz Zhanzakova; Saniya Abdrakhmanova
Journal:  PLoS One       Date:  2020-01-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.